Molecular Docking and ADMET Profiling of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin from Dalbergia sissoo: In Silico Prediction in Antidiabetic Potential. (2024). International Journal of Pharmaceutical Sciences and Drug Research, 16(5), 841-854. https://doi.org/10.25004/IJPSDR.2024.160512